Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Odyssey Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	2.98	4.47
Revenue Growth (YoY)	-33.45%	-
Gross Profit	2.98	4.47
Selling, General & Admin	37.52	27.12
Research & Development	126.62	112.58
Other Operating Expenses	-4.05	1.8
Operating Expenses	160.09	141.49
Operating Income	-157.11	-137.02
Interest Expense (Income)	-6.33	-8.47
Other Expense (Income)	-1.2	0.3
Pretax Income	-149.57	-128.85
Income Tax	-0.93	0.47
Net Income	-148.65	-129.32
Free Cash Flow	-488.03	-383.87
Gross Margin	100.00%	100.00%
Operating Margin	-5279.20%	-3063.98%
Profit Margin	-4994.86%	-2891.79%
Free Cash Flow Margin	-16398.96%	-8583.81%
EBITDA	-101.4	-72.25
EBITDA Margin	-3407.16%	-1615.70%
Depreciation & Amortization	54.51	65.07
EBIT	-155.91	-137.32
EBIT Margin	-5238.74%	-3070.73%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).